Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes

BACKGROUND: Nano-sized vesicles, so called extracellular vesicles (EVs), from regenerative cardiac cells represent a promising new therapeutic approach to treat cardiovascular diseases. However, it is not yet sufficiently understood how cardiac-derived EVs facilitate their protective effects. Theref...

Descripción completa

Detalles Bibliográficos
Autores principales: Beez, Christien M., Haag, Marion, Klein, Oliver, Van Linthout, Sophie, Sittinger, Michael, Seifert, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537224/
https://www.ncbi.nlm.nih.gov/pubmed/31133024
http://dx.doi.org/10.1186/s12951-019-0504-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537224/
https://www.ncbi.nlm.nih.gov/pubmed/31133024
http://dx.doi.org/10.1186/s12951-019-0504-0

Ejemplares similares